Regulation of epithelial syndecan-1 expression by inflammatory cytokines

Cytokine

Volumn 21, Issue 5, 2003, Pages 224-233

  Day, Richard M ^a   Mitchell, Tracey J ^b   Knight, Stella C ^b   Forbes, Alastair ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Colitis ulcerative; Crohn; Cytokine; Epithelium; Syndecan 1

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CELL STIMULATION; CELL STRAIN HT29; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENTERITIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0038798579     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00091-7     Document Type: Article

References (26)

1. Day R., Ilyas M., Daszak P., Talbot I., Forbes A. Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig Dis Sci. 44:1999;2508-2515.
2. Murch S., MacDonald T., Walker-Smith J., Levin M., Lionetti P., Klein N. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet. 341:1993;711-714.
3. Carey D. Syndecans: multifunctional cell-surface receptors. Biochem J. 327:1997;1-16.
4. Bernfield M., Kokenyesi R., Kato M., Hinkes M., Spring J., Gallo R., et al. Biology of the syndecans: a family of transmembrane heparan sulphate proteoglycans. Annu Rev Cell Biol. 8:1992;365-393.
5. Hayashi K., Hayashi M., Jalkanen M., Firestone J., Trelstad R., Bernfield M. Immunocytochemistry of cell surface heparan sulphate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem. 35:1987;1079-1088.
6. Rapraeger A., Krufka A., Olwin B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708.
7. Yayon A., Klagsbrun M., Esko J., Leder P., Ornitz D. Cell surface, heparin-like molecules are required for binding basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
8. Elenius K., Vainio S., Laato M., Salmivirta M., Thesleff I., Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol. 114:1991;585-595.
9. Tanabe H., Yokota K., Kohgo Y. Localization of syndecan-1 in human gastric mucosa associated with ulceration. J Pathol. 187:1999;338-344.
10. Stevens C., Walz G., Singaram C., Lipman M., Zanker B., Muggia A., et al. Tumour necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 37:1992;818-826.
11. Reinecker H., Steffen M., Witthoeft T., Pflueger I., Schreiber S., MacDermott R., et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 94:1993;174-181.
12. MacDonald T., Hutchings P., Choy M., Murch S., Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 81:1990;301-305.
13. Dionne S., Hiscott J., D'Agata I., Duhaime A., Seidman E. Quantitative PCR analysis of TNF-α and IL-1β mRNA in pediatric IBD mucosal biopsies. Dig Dis Sci. 42:1997;1557-1566.
14. Matthews N., Neale M. Cytotoxicity assays for tumour necrosis factor and lymphotoxin. Clemens M., Morris A., Gearin A. Lymphokines and interferons: a practical approach. 1987;221-225 IRL Press, Oxford.
15. Kainulainen V., Nelimarkka L., Järveläinen H., Laato M., Jalkanen M., Elenius K. Suppression of syndecan-1 expression in endothelial cells by tumour necrosis factor-α J Biol Chem. 271:1996;18759-18766.
16. Sneed T., Stanley D., Young L., Sanderson R. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cell Immunol. 153:1994;456-467.
17. Perry I., Tselepis C., Hoyland J., Iqbal T., Sanders S., Cooper B., et al. Reduced cadherin/catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation. Lab Invest. 79:1999;1489-1499.
18. Kato M., Bernfield M. Epithelial cells made deficient in syndecan lose cell surface expression of E-cadherin and β1-integrins. J Cell Biol. 111:1990;263a.
19. Leppä S., Vleminckx K., Van Roy F., Jalkanen M. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci. 109:1996;1393-1403.
20. Jalkanen M., Rapraeger A., Saunders S., Bernfield M. Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol. 105:1987;3087-3096.
21. Saunders S., Jalkanen M., O'Farrell S., Bernfield M. Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol. 108:1989;1547-1556.
22. Fitzgerald M., Wang Z., Pyong W., Park P., Murphy G., Bernfield M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol. 148:2000;811-824.
23. Seidel C., Sundan A., Hjorth M., Turesson I., Dahl I., Abildgaard N., et al. Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood. 95:2000;388-392.
24. Bloom S., Simons D., Jewell D. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Exp Immunol. 101:1995;157-163.
25. Subramanian S., Fitzgerald M., Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 272:1997;14713-14720.
26. Tarnawski A., Tanoue K., Santos A., Sarfeh I. Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol. 30:(Suppl 210):1995;9-14.